The activation of the NLRP3 inflammasome leads to the production of pro-inflammatory cytokines, notably interleukin-1β (IL-1β), which contribute to tissue damage and adverse cardiac remodeling post-MI. The gene discussed is NLRP3; the disease is myocardial infarction.